,title,source,link,date
0,Ajanta Pharma (NSE:AJANTPHARM) shareholders have earned a 21% CAGR over the last five years,Simply Wall St,news.google.com/articles/CBMinQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1hamFudHBoYXJtL2FqYW50YS1waGFybWEtc2hhcmVzL25ld3MvYWphbnRhLXBoYXJtYS1uc2VhamFudHBoYXJtLXNoYXJlaG9sZGVycy1oYXZlLWVhcm5lZC1hLTIxLWNh0gGhAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvaW4vcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnNlLWFqYW50cGhhcm0vYWphbnRhLXBoYXJtYS1zaGFyZXMvbmV3cy9hamFudGEtcGhhcm1hLW5zZWFqYW50cGhhcm0tc2hhcmVob2xkZXJzLWhhdmUtZWFybmVkLWEtMjEtY2EvYW1w?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-25
12,"Uveitis Treatment Market worth $1,281.23 million by 2030, growing at a CAGR of 8.41% - Exclusive Report by 360",openPR,news.google.com/articles/CBMiW2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMzAxMjYwL3V2ZWl0aXMtdHJlYXRtZW50LW1hcmtldC13b3J0aC0xLTI4MS0yMy1taWxsaW9uLWJ5LTIwMzDSAVpodHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMzAxMjYwL3V2ZWl0aXMtdHJlYXRtZW50LW1hcmtldC13b3J0aC0xLTI4MS0yMy1taWxsaW9uLWJ5LTIwMzA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
3,Deloitte India announces the third edition of the 'Best Managed ...,CXOToday.com,news.google.com/articles/CBMic2h0dHBzOi8vY3hvdG9kYXkuY29tL3ByZXNzLXJlbGVhc2UvZGVsb2l0dGUtaW5kaWEtYW5ub3VuY2VzLXRoZS10aGlyZC1lZGl0aW9uLW9mLXRoZS1iZXN0LW1hbmFnZWQtY29tcGFuaWVzLWF3YXJkcy_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-23
24,"Stocks To Watch: TCS, Infosys, Tata Steel, IndiGo, Welspun, Powergrid, TVS Motor, BPCL, Airtel, Mamaearth",BQ Prime,news.google.com/articles/CBMigQFodHRwczovL3d3dy5icXByaW1lLmNvbS9idXNpbmVzcy9zdG9ja3MtdG8td2F0Y2gtdGNzLWluZm9zeXMtdGF0YS1zdGVlbC1pbmRpZ28td2Vsc3B1bi1wb3dlci1ncmlkLXR2cy1tb3Rvci1icGNsLWFpcnRlbC1tYW1hZWFydGjSAYUBaHR0cHM6Ly93d3cuYnFwcmltZS5jb20vYW1wL2J1c2luZXNzL3N0b2Nrcy10by13YXRjaC10Y3MtaW5mb3N5cy10YXRhLXN0ZWVsLWluZGlnby13ZWxzcHVuLXBvd2VyLWdyaWQtdHZzLW1vdG9yLWJwY2wtYWlydGVsLW1hbWFlYXJ0aA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-22
